[Assessment of the endocrine status of peptic ulcer patients being treated with dalargin].
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D004381:Duodenal Ulcer / Q000097:blood / Q000188:drug therapy*; D004702:Endocrine Glands / Q000187:drug effects*; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D013997:Time Factors
D000897:Anti-Ulcer Agents; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Otsenka éndokrinnogo statusa u iazvennykh bol'nykh na fone lecheniia dalarginom.